BL1107 Eye Drops
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BL1107 Eye Drops, covering 2026-03-31 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension [Phase 2]